Genzyme/Geltex Pharmaceuticals Joint Venture Essay

2078 words - 8 pages

Early in 1997, Genzyme Corporation began negotiations with Geltex Pharmaceuticals in an attempt to launch a joint venture to market Geltex's first product, RenaGel. Geltex was a young biotech research company with only two products in its pipeline, and they didn't have the resources necessary to launch RenaGel on their own. Genzyme, on the other hand, was a quickly growing company that experienced revenues of $518 million in 1996. They were attracted to the joint venture with Geltex because of the likelihood of increased earnings, as well as the joint venture being an excellent fit for Genzyme's specialty therapeutics. Genzyme also felt that the joint venture would lead to a similar deal in launching Geltex's second product, CholestaGel. Before cementing a deal with Geltex, Genzyme managers had to ask themselves three questions:What is the likely enterprise value of the joint venture?How much of the venture should Genzyme acquire?How much should Genzyme pay for its interest?We will attempt to answer these questions by first giving a brief overview of the two companies involved, and then by calculating the Net Present Value of the joint venture based on expected cash flows. Because we were given no operating history of the two companies, this is the only method we will use to determine what interest Genzyme should take in the joint venture. We will provide answers in three different scenarios: Genzyme's estimates, conservative, and worst-case.Launched in 1981 by Henry Blair, Genzyme Corporation is the fourth-largest biotech company in America. What differentiates Genzyme from its competition is that it uses living organisms or their products to generate drugs, rather than chemicals. Genzyme made its name in the industry with Ceradase, a treatment for Gaucher's disease. This drug was approved for sale in March of 1991 and had a market of 3000 people. Two years later a recombinant form of Ceradase was released and the company began to enter new markets through alliances, joint ventures, and acquisitions. Genzyme quickly became a leader in its industry. The broad array of products and services Genzyme provided gave the company an ample platform to work with in achieving medical breakthroughs. However, the company decided to outsource innovations through partnerships rather than focusing on developing the next miracle drug. They felt this strategy would lead to higher quality products in late-stage development, which increased the likelihood of the product being approved by the FDA.Geltex is a company founded in 1992 by George Whitesides, Dr. James Tananbaum, Bob Carpenter, and Henry Blair. The company was started to develop Whitesides's ideas involving using polymers as drugs. Eight initial investors generated $875,000 to fund the startup, which lasted a year. One year later, $6.8 million was raised from venture capitalists, and the company moved into a new facility in Lexington. In 1994, $10 million more was raised in another round of financing....

Find Another Essay On Genzyme/Geltex Pharmaceuticals Joint Venture

Pharmacia Essay

1596 words - 6 pages facilities outside the United States, Belgium in 1963 and Puerto Rico in 1974. The first venture out of pharmaceuticals was into animal health. Upjohn has added other agricultural products over the years. They acquired Asgrow Seeds in 1986 to develop new strains of crop seeds. In 1986, a joint venture was formed with Tyson Foods. Upjohn also began diversifying into nonagricultural products with the purchase of Carwin Company. Carwin as then combined with

Country Report of China and Healthcare Industry

3453 words - 14 pages profit fiscal year ending 2005 showed 8 billion USD, with an increase of 19% over fiscal year 2004.oXian-Janssen is a sino-US joint venture between Johnson & Johnson Ltd. and Xian pharmaceuticals. It is the one of the most profitable joint venture companies in China, and is able to provide a wide range of products and formulations.Financial data was unavailable, since the company is a part of Johnson & Johnson.oAstraZeneca PLC is another top 5

Monsanto Corporation

1155 words - 5 pages Monsanto Corporation was originally a part-time venture manufacturing saccharin. From early 1900s to the end of the 20th century it went through a series of changes and in 1997 it is a $US billion multinational life sciences company. Although, Monsanto has operated historically in the chemicals industry, it has undertaken initiatives to be a major player in biotechnology, pharmaceuticals, and food ingredients.The new management team had

Johnson And Johnson Report

2043 words - 9 pages s and was pulled from the shelves.New products in the 1980's included ACUVUE (disposable contact lenses) and Retina. The company bought LifeScan (blood-monitoring products for diabetics) in 1986. In 1989 Johnson and Johnson began a joint venture with Merck to sell Mylanta and other bought from ICI Americas.Johnson and Johnson continued its acquisition and diversification strategy in the 1990's. After introducing the first daily-wear, disposable

An Analysis of Indian Economic Reforms

962 words - 4 pages the market and established supply system, while the domestic company do this for FDI and new technology. Joint Venture: Joint Venture is an agreement between two companies that they would work together for a finite time. They would control the operations together and split the revenues and costs. Will India sustain the growth? The answer is not easy to say, as markets have become extremely volatile and anything can happen over short period of

Ready

3569 words - 14 pages Entering Foreign Markets and Strategic Alliances [T] Chapter 9 [C] Group 3 Case: Vietnam: Market Entry Decisions March 3 [R] Ohmae, "The Global Logic of Strategic Alliances" [C] Group 4 Case: Milkpak Limited - International Joint Venture March 5 Mid-Term Exam I March 10 & 12 Spring Break III. MARKETING MIX

The case of the furniture sector in China

3782 words - 15 pages ltd.P489Establishing a joint venture with a foreign firm has long been a popular mode for entering a new market. Given the market analysis and Hong Leong financial situation, joint venture is also the most suitable strategy. By entering a joint venture with a well-developed Chinese company, Hong Leong can benefit from the local partner's knowledge of the China's competitive conditions, culture, political systems and business systems. Also it can

ifrs

1201 words - 5 pages challenge in the areas of accounting for employee benefits and share based payments. This sector is likely to have low to medium impact. The study highlights that revenue recognition, lease accounting, impairment of assets, consolidation, joint venture, sales tax deferral loan, intangibles and borrowing costs as the major impact areas for automobile industry. Telecom industry may have problems in revenue recognition, PPE, financial instruments and

Harvard Business School case: Smithkline Beecham. Corporate strategy. Scope, Scale,5 forces, SWOT, Direction, long term, Competitive advantages, Stakeholders

3045 words - 12 pages throughput screening technology (LJL Biosystems);·genomics·biotech / bioinformatics;·venture capital.·governments;·doctors;·hospitals;·pharmacies;·consumers.Which needs to fulfilWhich activities·Prevention·Diagnosis·Treatment·CureDivisions of SB as of 1992·SB Pharmaceuticals; ·SB Consumer Brands; ·SB Animal Health; ·SB Clinical

The movement of professional jobs to India and China

1989 words - 8 pages rights. In China, companies formerly did much R&D in joint venture with Chinese firms or universities. Now they are abandoning the joint-venture model in favor of wholly foreign-owned enterprises, to make sure anything they develop in the R&D centers is their own property.Are biotech R&D jobs next to go?Biotechnology is often thought of as the savior that will help replace the hundreds of thousands of jobs lost to outsourcing. People

Cluster based Economic development

1954 words - 8 pages and large corporations including multinationals (MNCs), joint-venture or partnerships collaborations and domestic entrepreneurs needs strategic industrial location to start with as their operations base. The industrial estates are seemed acted as enablers for industry development to produce an ecosystem that will attract investment to generate high value-added industrial development and create employment in the specific industry and region. 2.2

Similar Essays

Management Paper

3151 words - 13 pages direct competition that EntreMed faces is the biotechnological companies that are also specialize in the oncology and developing cures for cancer that include Amgen, Affymax, Onyvax , Angiotech Pharmaceuticals, Antigenics, ImClone Systems, etc. The indirect competition includes the bigger players in the industry such as Genzyme, MedImmune, DepoMed, Human Genome Sciences, etc.1.3 Current Financial InformationKey Financial RatiosLatest 12 Months3-Year

Eli Lily And Ranbaxy Case Essay

2889 words - 12 pages benefit from each other.Reference ListAgarwal S P, Gupta A, Dayal R. 2007. Technology Transfer Perspectives in Globalising India (Drugs and Pharmaceuticals and Biotechnology. Journal of Technology Transfer 32: 397-423.Asian Health Newsletter, June, 2007, http://www.bdallc.com/bda_pdf/health/Asian%20Health%20Newsletter%20Jun%202007.pdfBartlett, Ghosal and Beamish. 2008. Eli Lilly in India: Rethinking the joint venture strategy, Transnational Management

Alpes Case Study

2484 words - 10 pages Untitled Executive Summary Dennis Shaughnessy the senior vice-president for Corporate Development and general counsel for Charles River Laboratories (CRL) is facing many problems trying to implement a joint venture with ALPES a SPF egg producer in Mexico. The proposal is to invest $2 million into a joint venture located in Mexico to capitalize on the expected growth margin of Specific Pathogen Free eggs (SPF Eggs). Revenues are

Strategies In Action Essay

3264 words - 13 pages manner.The simple classical approach that will be discussed is the joint venture organization, whose primary focus is on the local perspective allowing for shareholder control of corporate strategy. The objective here is typically a cost management strategy as opposed to a more innovative outlook.On the other hand, the complex network approach, which focuses on organizational partnerships, has different characteristics which can be categorized into three